FFB
NBIX icon

First Financial Bankshares’s Neurocrine Biosciences NBIX Stock Holding History

First Financial Bankshares’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.59M Buy
39,127
+630
+2% +$93.5K 0.12% 75
2026
Q1 		$5.07M Buy
38,497
+644
+2% +$85.4K 0.1% 79
2025
Q4 		$5.37M Buy
37,853
+9,427
+33% +$1.37M 0.11% 75
2025
Q3 		$3.99M Sell
28,426
-152
-0.5% -$20.6K 0.08% 83
2025
Q2 		$3.59M Buy
28,578
+807
+3% +$92.5K 0.08% 83
2025
Q1 		$3.07M Buy
27,771
+829
+3% +$105K 0.07% 81
2024
Q4 		$3.68M Buy
26,942
+9,208
+52% +$1.14M 0.08% 81
2024
Q3 		$2.04M Buy
17,734
+1,058
+6% +$145K 0.04% 93
2024
Q2 		$2.3M Buy
16,676
+483
+3% +$66.2K 0.05% 87
2024
Q1 		$2.23M Buy
16,193
+391
+2% +$53.4K 0.05% 91
2023
Q4 		$2.08M Buy
+15,802
New +$1.82M 0.05% 93

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

First Financial Bankshares's NBIX Position: Q2 2026 in Review

First Financial Bankshares increased its Neurocrine Biosciences (NBIX) stake by 1.6% in Q2 2026, buying an estimated $93.5K and bringing the position to 39,127 shares worth $6.59M. The position accounts for 0.12% of the portfolio, ranked #75.

First Financial Bankshares first reported a position in NBIX in Q4 2023 and has held it in 11 quarters since. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • First Financial Bankshares held 39,127 shares of Neurocrine Biosciences worth $6.59M as of Q2 2026.
  • First Financial Bankshares bought 630 Neurocrine Biosciences shares in Q2 2026, an estimated $93.5K.
  • Neurocrine Biosciences made up 0.12% of First Financial Bankshares's portfolio in Q2 2026, its #75 holding.
  • First Financial Bankshares first reported a position in Neurocrine Biosciences in Q4 2023 and has held it in 11 quarters since.
  • 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on First Financial Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.